“…Secreted CCN1, which may be quantified by CCN1 staining at the cytoplasm, can act on glomerular cells in a GBM-bound form, since CCN1 has a high affinity for heparan sulfate proteoglycans (37), a major component of the GBM (8). Furthermore, CCN1 interacts with a variety of integrins (3,9,14,19,28), e.g., acting through integrin ␣ v  3 on endothelial cells and through ␣ v  5 on fibroblasts (9,14), both of which are expressed in mesangial cells and podocytes (10). It was recently reported that production of vascular endothelial growth factor A, a homodimeric glycoprotein of 48 kDa, from podocytes is required for mesangial cell survival in vivo (6), suggesting that secreted factors from podocytes can act on glomerular cells, counteracting against the flow from the capillary lumen to the urinary space.…”